Evidence map›Paper›PMID 41872663›Full record

ReviewClinical rheumatology2026

Efficacy of telitacicept in a refractory systemic lupus erythematosus patient with lupus nephritis and subsequent pregnancy: a case-based review.

Jinhui Tan, Hai Huang, Linghua Tan, Yuhuan Luo

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinhui TanDepartment of Rheumatology and Immunology, People's Hospital of Longhua, Shenzhen, Shenzhen, Guangdong, 518109, China. 15015093514@163.com.ORCID http://orcid.org/0009-0004-9077-1593
Hai HuangDepartment of Health Management, People's Hospital of Longhua, Shenzhen, Shenzhen, Guangdong, 518109, China.
Linghua TanDepartment of Health Management, Jiangmen Wuyi Hospital of Chinese Medicine, Jiangmen, Guangdong, 529099, China.
Yuhuan LuoJingxin Community Health Center, People's Hospital of Longhua, Shenzhen, Shenzhen, Guangdong, 518109, China.

Funding

the Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen 2022046
6 · The paper itself

Abstract

This case report describes a 31-year-old woman with refractory systemic lupus erythematosus (SLE) and lupus nephritis (LN) who achieved clinical remission following a treatment regimen that included telitacicept, in combination with cyclosporine, hydroxychloroquine, and low-dose prednisone. Despite counseling on teratogenic risk and advice for contraception, an unplanned pregnancy occurred. Telitacicept was promptly discontinued upon pregnancy confirmation, and disease control was maintained with cyclosporine A and low-dose prednisone. Due to maternal hypothyroidism, a cesarean section was performed at 37⁺

Indexed as

Lupus Erythematosus, SystemicLupus NephritisPregnancy ComplicationsAdultCyclosporineDrug Therapy, CombinationFemaleHumansHydroxychloroquineImmunosuppressive AgentsPrednisonePregnancyPregnancy OutcomeRecombinant Fusion ProteinsTreatment OutcomeCyclosporineHydroxychloroquineImmunosuppressive AgentsPrednisoneRecombinant Fusion ProteinstelitaciceptCase reportLupus nephritisPregnancySystemic lupus erythematosusTelitacicept

Identifiers

PMID41872663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.